DUPUYTREN RESEARCH GROUP INC
WEST PALM BEACH, FLORIDA

DUPUYTREN RESEARCH GROUP INC, headquartered in West Palm Beach, Florida, is an organization fully dedicated to finding a cure for Dupuytren disease. Established on October 19, 2015, it operates under the Florida company type 'DOMNP' and holds the filing number N15000010169. The group's mission is to expedite research efforts aimed at curing Dupuytren Disease by focusing on its underlying biological causes rather than just treating its symptomatic manifestations. Guided by Dr. Charles Eaton, the Executive Director, and supported by an international team from prestigious academic institutions, the organization has developed initiatives such as the International Dupuytren Database (IDDB) to propel forward a research-centric approach. Dupuytren disease affects millions of Americans, manifesting as permanently bent fingers due to the tightening of palm tissues. Despite treatments available for alleviating the condition's effects through surgical procedures, no cure currently exists, with treatments often not preventing recurrence or further progression of the disease. This motivates the Group's aim to discover a definitive cure. The organization boasts global reach, with members from all 50 states and across 70 countries, including former board member Keith Raskin and current members Gary Pess. The Dupuytren Research Group is committed not only to advancing research but also to providing patient support, hosting academic conferences, and authoring publications. The group's efforts are critical in the pursuit of a permanent solution to this condition that can impact quality of life significantly. For more information, visit their website at dupuytrenfoundation.com.